Oncolytics Biotech Inc. is a publicly traded biotechnology company that focuses on the development of oncolytic viruses as potential cancer treatments. They aim to harness the body’s immune system to fight cancer and have multiple clinical trials underway. With a strong emphasis on research and development, they are at the forefront of innovative cancer therapies.
